The Immunotherapy for Colorectal Cancer, Lung Cancer and Pancreatic Cancer.

Int J Mol Sci

Jenteh Junior College of Medicine, Nursing and Management, Hou-Loung Town, Miaoli County 35664, Taiwan.

Published: November 2021

Immunotherapy is a novel anti-cancer method which employs a different mechanism to conventional treatment. It has become a significant strategy because it provides a better or an alternative option for cancer patients. Recently, immunotherapy has been increasingly approved for the treatment of cancer; however, it has various limitations; for instance, it is only suitable for specific patients, the response rate is still low in most cases, etc. Colorectal cancer, lung cancer and pancreatic cancer are known as three major death-causing cancers in most countries. In this review, we discuss immunotherapeutic treatment for these three cancers, and consider the option, prospects and limitations of immunotherapy. The development of immunotherapy should focus on the discovery of biomarkers to screen suitable patients, new targets on tumors, neoadjuvant immunotherapy and the combination of immunotherapy with conventional therapeutic methods. We can expect that immunotherapy potentially will develop as one of the best therapies for patients with advanced cancer or poor responses to traditional methods.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657810PMC
http://dx.doi.org/10.3390/ijms222312836DOI Listing

Publication Analysis

Top Keywords

cancer
9
immunotherapy
8
colorectal cancer
8
cancer lung
8
lung cancer
8
cancer pancreatic
8
pancreatic cancer
8
immunotherapy colorectal
4
cancer immunotherapy
4
immunotherapy novel
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!